Parents of preschoolers with Prader-Willi Syndrome (PWS) tend to be relatively more stressed and overinvolved in interactions with their children,…
Marisa Horak, MS
Marisa holds a Master of Science in cellular and molecular pathology from the University of Pittsburgh, where she studied novel genetic drivers of ovarian cancer. Her areas of expertise include cancer biology, immunology, and genetics, and she has worked as a science writing and communications intern for the Genetics Society of America.
At Bionews we’re committed to providing the most accurate, relevant, and up-to-date reporting for our patient communities. Our goal is to ensure that everyone has access to disease-specific information that is both trustworthy and easy to understand. You can read more about our editorial policy here.
Articles by Marisa Horak, MS
A new funding deal will aid Saniona‘s development of Tesomet (tesofensine/metoprolol), a potential therapy to help control…
Target enrollment of approximately 100 participants has been reached in a Phase 3 clinical trial evaluating the investigational oral therapy…
Medix has submitted a new drug application to the Mexican food and drug administration — Comisión Federal para…
Caregivers of young children with Prader-Willi syndrome (PWS) report low quality of life, highlighting the need for additional support…
Prader-Willi syndrome (PWS) has been given its own unique code by the National Center for Health Statistics (NCHS),…
Results of a Phase 2 clinical trial testing diazoxide chloride controlled release (DCCR) in people with Prader-Willi syndrome…
There is a wide range of long-term testicular function and cell-level appearance in males with Prader-Willi syndrome (PWS), a new…
A new study suggests that people with Prader-Willi syndrome (PWS) who are treated with growth hormone as children do not…
Infants with Prader-Willi syndrome can show abnormalities in motor and verbal development within the first six months of life, a…